Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Allergan News Editors

News Widget

Display the Allergan news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Allergan News

News on Allergan (Ticker: AGN) continually updated from thousands of sources around the net.

Friday May 25 | Barron's

Goldman Pharma View: Buy Agn, Sell FRX, MRX a Takeover Target

A recent selloff in specialty pharmaceuticals has creating a buying opportunity, according to Goldman Sachs analyst Gregory Waterman , but he thinks investors should be discriminating.

Comment?

Related Topix: Goldman Sachs, Financial Services, Investment Services, Biotech

Tue May 22, 2012

Investopedia

Oversold Market Leads to Opportunities

Stocks around the globe have been taking a hit during the month of May, which has pushed the major stock indexes into oversold territory.

Comment?

Related Topix: Financial Markets, Biotech

Mon May 21, 2012

Customer Interaction Solutions

Post Earnings Update: Allergan Has Sunk 4.0% Lower in Past 2 Weeks

May 21, 2012 News Watch via COMTEX) -- When Allergan reported earnings two weeks ago on May 2nd, 2012, analysts, on average, expected the company to report earnings of $0.87 on sales of $1.4 billion.

Comment?

Related Topix: Biotech, Financial Markets

Fri May 18, 2012

BioSpace

Allergan Inc. to Build R&D Plant, Add 400 Jobs in New Jersey

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Allergan, which makes Botox, will build a nearly $12 million research and development facility in Bridgewater, the company and the site's owner, SJP Properties, announced ... (more)

Comment?

Related Topix: Biotech

Thu May 17, 2012

GlobeSt.com

Allergan Signs 93,000 SF in Somerset Center

Join the thousands of real estate professionals that subscribe to the New Jersey AM Alert.

Comment?

Related Topix: Biotech, New Jersey, Bridgewater, NJ, Rutgers University

Fri May 11, 2012

BioSpace

National Institute for Clinical Excellence (NICE) Backs Allergan...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia The cost regulator for the U.K.'s publicly-funded National Health Service has reversed its earlier stance on U.S.-based Allergan Inc.'s wrinkle-fighting drug Botox and now ... (more)

Comment?

Related Topix: Biotech

World News Report

Amakem Appoints Dr. Steve Pakola as Chief Medical Officer; Dr. George ...

Both have exceptional track records in the biotechnology industry and bring a wealth of ophthalmology experience to Amakem.

Comment?

Related Topix: Ophthalmology, Medicine, Biotech

Thu May 10, 2012

Fermanagh Today

Botox for migraines on NHS closer

Health watchdog the National Institute for Health and Clinical Excellence has published final draft guidance which recommends the anti-wrinkle jab for the condition.

Comment?

Related Topix: Biotech

Wall St. Cheat Sheet

Cramer Stock Watch: Buy Apple, Celgene and Sell These 2 Stocks Now

Apple Inc. : Jim Cramer ranked this stock a Buy . The stock closed at $569.18, its 52-week high is $644.00, and its 52-week low is $310.50. Allergan Inc.

Comment?

Related Topix: Apple, Biotech, Startups, Celgene, Medicine, Healthcare Industry, Amerigas Partners lp, Energy, Oil & Gas, Atmel

Business World

EU force cosmetics trademark withdrawal

In an EU row over trademarks, Helena Rubinstein and L'Oreal have been told to withdraw their brands "Botolist" and "Botocyl" respectively.

Comment?

Related Topix: Biotech

Seeking Alpha

Cramer's Mad Money - 7 Growth Stocks To Buy On Down Days

Apple , Starbucks , Chipotle Mexican Grill , Ross Stores , Allergan , Celgene , Lululemon .

Comment?

Related Topix: Financial Markets, Apple, Startups, Chipotle Mexican Grill, Restaurant Management, Starbucks, Biotech, Ross Systems, Software

Tue May 08, 2012

Medical News

ACADIA first quarter net loss increases to $6.2 million

ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the first quarter ended March 31, 2012.

Comment?

Related Topix: Biotech, Medicine, Health

Wall St. Cheat Sheet

4 S&P 500 Stock Sales to Review in May

Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for May 4th.

Comment?

Related Topix: Visa Inc., Financial Services, Automatic Data Processing, Biotech, Medicine, Stryker, Medical Equipment, Healthcare Industry

Mon May 07, 2012

Bloomberg

Allergan Receives U.S. Subpoena Over Lap-Band Device for Weight Loss

Allergan Inc. , the maker of the wrinkle treatment Botox, received a U.S. government subpoena over its gastric banding device for obesity.

Comment?

Related Topix: Biotech

Fri May 04, 2012

AmericanBankingNews.com

Zacks Reiterates "Neutral" Rating on Allergan

's stock had its "neutral" rating reiterated by Zacks in a research note issued to investors on Friday.

Comment?

Related Topix: Biotech, Investment Banking, Financial Services, Jefferies Group, Investment Services, Banking, Bank of America

Thu May 03, 2012

Wall St. Cheat Sheet

Healthcare Business Recap: Herbalife, Allergan and More

Shares of Smith & Nephew rise sharply as its first quarter trading profit, boosted by knee replacements and wound care, of $252 million compared to $241 million year-to-year becomes known.

Comment?

Related Topix: Biotech, Vicept Therapeutics, Allergan, Smith and Nephew, Medical Equipment, Insurance, Health Net, Medicaid, Health

Wall St. Cheat Sheet

Allergan, Inc. Earnings Call Nuggets: 2Q Guidance, Duet Dividends

On Wednesday, Allergan, Inc. reported its first quarter earnings and discussed the following topics in its earnings conference call.

Comment?

Related Topix: Biotech

AmericanBankingNews.com

Allergan Given New $95.00 Price Target at Jefferies Group

The analysts wrote, "AGN reported 1Q revs slightly above the Street, but EPS a penny below consensus, and guided to 2Q below expectations while maintaining full-year guidance.

Comment?

Related Topix: Investment Banking, Financial Services, Jefferies Group, Investment Services, Biotech

Wed May 02, 2012

MarketNewsVideo

Daily Dividend Report: AXP, AGN, TYC, PEP, ABX

American Express Company maintained its quarterly dividend of 20 cents per share.

Comment?

Related Topix: Financial Services, Travelers Express Company, Biotech, TYCO International, Security, Beverages, PepsiCo, Business News, Video

Fox News

Allergan's Profit Rises 45% On Stronger Botox Sales

Allergan Inc.'s first-quarter earnings rose 45% as the maker of Botox and medical devices reported double-digit sales growth at its specialty pharmaceuticals business.

Comment?

Related Topix: Biotech, Vicept Therapeutics, Allergan, Business News

Los Angeles Jobs

Also on Topix